Laryngeal Cancer
40
11
11
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
2 terminated out of 40 trials
86.7%
+0.2% vs benchmark
5%
2 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (40)
Integrated Cancer Repository for Cancer Research
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
Workshops and Exchange Groups for Laryngectomized Patients
Validation of End-to-End Difficult Airway Pathway Planning Algorithm (EAP-LC)
Pembrolizumab in Combination With CRT for LA-SCCHN
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients
SpeakFree Heat and Moisture Exchanger (HME)
Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
Study of the Risk of Pharyngocutaneous Fistula in a Population of Patients Undergoing Total Laryngectomy and Creation of a Score for Pre-operative Risk Stratification.
Resistance Training and Physical Functioning in Head and Neck Cancer Patients
Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
Immune Biomarker Study for Head and Neck Cancer
Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer